The 10th CAR-TCR Summit Europe presents the latest advances, clinical data, and scalable strategies in CAR-T and TCR cell therapies for oncology and immunotherapy.
Key Topics
Advancing Next-Generation TCR Therapies targeting ROPN1 for triple-negative breast cancer
Clinical data showcase validating breakthrough CAR-T therapies
CAR-NK & CAR-Treg approaches for scalable and safe treatments
Automation and advanced platforms for CAR-T manufacturing
AI & machine learning to accelerate R&D and receptor construct design
Regulatory landscapes and pathways for global cell therapy development
In-vivo CAR-T therapies with lipid nanoparticle and episomal DNA delivery
Precision protein delivery platforms and immune-activating therapies
Patient access frameworks and hospital exemption strategies in Europe
Non-viral gene-edited manufacturing for TCR-T therapies
Next-generation off-the-shelf CAR-NK therapies
Overcoming analytical bottlenecks and standardizing CAR-T monitoring
Lean and efficient manufacturing to accelerate cell therapy development
Ethics, funding, and investment strategies for clinical and commercial growth
Novel receptor designs, dual-targeting, and armouring strategies to improve efficacy
Who should Attend
Biotech and pharmaceutical executives
Cell therapy and immunotherapy researchers
Clinical development and translational scientists
Manufacturing and process development professionals
Investors and funding agencies in biotech
Regulatory affairs and compliance specialists
Academic scientists focused on oncology and immunology
Hospital and clinical site leaders managing CAR-T programs
